Skip to main content
PLOS One logoLink to PLOS One
. 2021 Apr 28;16(4):e0250787. doi: 10.1371/journal.pone.0250787

A dynamic Bayesian network model for predicting organ failure associations without predefining outcomes

Roberto Alberto De Blasi 1,*, Giuseppe Campagna 1, Stefano Finazzi 2
Editor: Moshe Zukerman3
PMCID: PMC8081190  PMID: 33909682

Abstract

Critical care medicine has been a field for Bayesian networks (BNs) application for investigating relationships among failing organs. Criticisms have been raised on using mortality as the only outcome to determine the treatment efficacy. We aimed to develop a dynamic BN model for detecting interrelationships among failing organs and their progression, not predefining outcomes and omitting hierarchization of organ interactions. We collected data from 850 critically ill patients from the national database used in many intensive care units. We considered as nodes the organ failure assessed by a score as recorded daily. We tested several possible DBNs and used the best bootstrapping results for calculating the strength of arcs and directions. The network structure was learned using a hill climbing method. The parameters of the local distributions were fitted with a maximum of the likelihood algorithm. The network that best satisfied the accuracy requirements included 15 nodes, corresponding to 5 variables measured at three times: ICU admission, second and seventh day of ICU stay. From our findings some organ associations had probabilities higher than 50% to arise at ICU admittance or in the following days persisting over time. Our study provided a network model predicting organ failure associations and their evolution over time. This approach has the potential advantage of detecting and comparing the effects of treatments on organ function.

Introduction

Since the early 2000s, Bayesian networks (BNs) have attracted considerable interest in the field of medicine [1] for their ability to model complex systems by learning the network structure among variables from observed data, thus providing an interpretation of causal relationships among variables instead of merely capturing associations [2]. In critical care medicine, BNs have been applied clinically to investigate the complex relationship among failing organs. Since the 1990s, many criticisms have been raised regarding the use of mortality to reflect the efficacy of a treatment, particularly when the disorder under consideration has limited lethality [3]. Despite these concerns, in most clinical trials resorting to predefined outcomes continues to be the predominant criterion for evaluating whether a therapeutic action is effective [4].

In this work, we considered the onset of organ failure and used BNs to determine the probabilities of connections among failing organs that could be assumed to reflect the effects of therapeutic actions.

The use of dynamic Bayesian networks (DBNs) added to BNs is beneficial for investigating the temporal order and duration of organ failures, helping to predict the most likely progression during a patient’s stay in the intensive care unit (ICU) [5, 6].

To make DBN prediction reflective of the pathophysiological process of organ failure in critically ill patients without constraining the network structure with a priori assumptions, we adopted an approach that differed from the procedures commonly employed for BN applications in health care. This process normally entails a two stage process to assess conditional probabilities [7]. The first stage is the identification of possible dependence relationships between variables. This stage involves manually defining causal relationships represented by directed arcs between network nodes. The second stage includes the identification of qualitative probabilistic and logical constraints, reducing the number of parameters to be estimated. On the one hand these procedures have the advantage of making the network robust and clinically interpretable on the basis of existing knowledge. On the other hand, imposing ordering and constraints on the probabilistic relationships between organs and processes can limit the ability of the model to reflect the data.

Given that multiple organ dysfunction syndrome (MODS) arises from a widespread septic or non-septic inflammatory reaction involving tissue microcirculation the associations and sequences of organ failure events are not shaped by trivial causal relationships or constraints [8, 9].

Contrary to previous studies that used DBNs to predict the dynamics of failing organs by hierarchizing organ interactions and forcing discrete outcomes [6, 10], our study aimed to develop a model for identifying interrelationships among organs without defining a specific outcome as a reference and without hierarchizing organ interactions. Since relationships among failing organs are complex and not completely known, we decided to learn the causal structure of a short-term DBN from data with Markovian constraints enforced through a blacklist of temporal relationships. In addition, we built a DBN by learning the associated structure and estimating parameters connected with conditional probabilities. We initially included an extensive set of organs and data points and gradually reduced them to a minimum clinically relevant group.

Materials and methods

We included data retrospectively collected from the “Prosafe” database of the Italian Group for the Evaluation of Interventions in the Intensive Care Units (https://givitiweb.marionegri.it). Data collection was approved by the the ethics committee of the Sapienza University of Rome at the Sant’Andrea University Hospital (Ref. 3408 2014/09.10.2014, Prot. 1244/2014), and all subjects provided written informed consent. Data were derived from patients admitted to the adult intensive care units (ICUs) of the Sant’Andrea University Hospital in Rome, the A. Manzoni Hospital in Lecco and the Di Cristina-Benfratelli Civic Hospital in Palermo, Italy, from January to September 2013. We collected data from patients with at least two organ failure events and a hospital stay longer than 48 hours so that the organ interactions and their progression could be assessed.

For patients who had multiple ICU admissions, we considered only the first admission. During their ICU stay, patients were treated according to the usual clinical practice of the period of data collection and received organ function support when needed (i.e., mechanical ventilation, hemodialysis and/or vasopressors).

For the DBN construction, we included as nodes the same organs considered for the Sequential Organ Failure Assessment (SOFA) score [11], and the observation times (t) were the days of data collection for the included organs and systems: cardiovasculart (CV), respiratoryt (lung), central nervous system (CNS)t, renalt (kidney), livert (Liver) and coagulationt (C). The SOFA score was computed using data collected from laboratory tests, cardiovascular monitoring, vasoactive drug dosages and clinical reports. A failure event for an organ was defined as a SOFA score greater than or equal to two [12]. For each patient, we collected daily data recordings for 7 consecutive days after ICU admission through an ad hoc electronic case report form. This interval was chosen because it approximatively matches the patients’ mean ICUs stay, as previously reported (https://givitiweb.marionegri.it). A day was defined as a 24 h period starting at 12.00 a.m. except for the first day (t0), the day of ICU admission. If a patient was admitted before 12:00 p.m., t0 was defined as the 24 h period already in progress, starting at 12:00 a.m.; if the time of admission was after 12:00 p.m., the remaining hours until 12:00 a.m. were pooled with the following day.

Bayesian networks

A Bayesian network is a probabilistic directed acyclic graph depicted as nodes, which represent random variables, and arcs between nodes, which express the probabilistic dependencies between variables. The direction of the arc (arrow) between two nodes, A and B, establishes a “parent” node (A) and a “child” node(B).

DBNs extend BNs by encoding the temporal or spatial evolution of variables expressed by repeated time series models [13, 14]. Assuming n random variables, X = X1, X2, , Xn, we constructed a DBN by adding a node (i) for each variable at each time step t (Xti). For a dynamic model, we assumed that the state of the system at t would affect the future state of the variables at t+1 and would depend on the previous configuration at t-1 [15]. Causal relationships follow the arrow of time: the state of any node at a given instant can influence the states of nodes in the future but never in the past [16]. Furthermore, we assumed that the Markov property held true, implying that the stochastic process underlying the onset of organ failure was memoryless. As a consequence of this assumption, states of nodes in the network at time t depend exclusively on nodes states at t and t– 1 (but not at t–j, with j > 1) [17].

Dynamic Bayesian network formulation

All computations were performed using R software and the package bnlearn (https://www.bnlearn.com/releases/bnlearn_latest.tar.gz). The network structure was learned from data using the hill-climbing algorithm [18] starting from an empty network (a network with no arcs). We used a blacklist to exclude unreasonable temporal causal relationships (arcs directed from the future to the past) and enforce the Markovian properties (arcs could link nodes only at the same time or between time t and t– 1). The score used in the optimization process was the Bayesian information criterion.

To obtain a more robust model with higher predictive performance [19], we constructed an averaged network through bootstrapping. We generated 500 realizations of the network structure through the function bn.boot with the hill climbing algorithm [20]. Arc strength was computed as the fraction of realizations in which the arc was selected by the hill-climbing algorithm. Arc direction was the fraction of realizations in which the arcs had a given direction. We retained only arcs with directions greater than or equal to 0.5 and with strengths greater than an optimal threshold, automatically determined based on the shape of the cumulative distribution of arc strengths [19].

Once the network structure was determined, the probability matrices representing the probability of each node, conditional on the value of its parent node were estimated with a maximum likelihood algorithm using the function bn.fit. We considered 4 possible DBNs with different number of nodes.

In the first network, we used variables for all organs (6 nodes) for eight days. Given that the platelet count changes according to the duration and severity of sepsis and mostly cannot be affected by a specific treatment, node “C” was omitted from the second network. We also tested a third network including 6 nodes at three time points: t0 = day of ICU admission, t2 = 2nd day and t7 = 7th day. This network was also tested without the platelet count (C node). To test the model reliability, we applied a k-fold cross-validation analysis to this final network, with k = 10. We computed the sensitivities and specificities of the child node predictions from parent nodes.

Results and discussion

Characteristics of patients and networks

We enrolled 850 patients ranging in age from 18.0 to 95.0 years (median: 69.0), with a mean of 65.7 ± 15.9. Of these, 536 (63.1%) were male (mean age 65.6 ± 15.5 years, range 18.0–95.0), and 314 (36.9%) were female (mean 65.9 ± 16.7 years, range 18.0–93.0). The number of discharged patients was 651 (76.6%), of whom 410 were male (63.0%) and 241 were female (37.0%). The mean age of the males did not differ significantly from that of the females. The mean ages of the discharged patients were 64.4 ± 16.2 years (male) and 69.2 ± 14.3 years (female). There were 199 (23.4%) deaths, of which 126 (63.3%) decedents were male and 73 (36.7%) were female. The mean age of the patients who died was 69.2 ± 14.3.

The type of organ failure at ICU admission were as follows: lung = 44.5%, CV = 36.1%, CNS = 32.7%, liver = 11.2% and kidney = 7.6%. Anonymous data are available in the repository as DATASET SOFA. DANS. https://doi.org/10.17026/dans-zgz-7keg.

Networks

Based on the bootstrap analysis, strength and direction values were robust if they exceeded the threshold value of 0.47 for strength and we assigned the conventionally adopted value of 0.5 for direction. The first network (6 nodes for 8 days) had 54 nodes and 74 direct arcs, with average Markov blanket size of 3.33. The 2nd network included 45 nodes and 60 direct arcs, with a Markov blanket size of 3.16. The 3rd network showed 18 nodes and 22 direct arcs, a Markov blanket size of 3.00 and a cutoff value of 0.64 when “C” was included, whereas without the “C” node, the number of nodes was reduced to 15 and the number of arcs to 19, with a Markov blanket size of 3.20. The network analysis produced the following findings: after bootstrapping, the structure of the 1st network deviated from the original one and the strengths of 12 arcs and 15 directions were lower than the cutoff value of 0.49. In the 2nd network, 2 of 60 arcs deviated from the original structure after bootstrapping, and 9 arcs and 14 directions were below the strength cutoff of 0.48.

In the 3rd network including C, 3 of 22 arcs differed from the original structure after bootstrapping, and 6 arcs and 8 directions were below the strength cutoff of 0.48. When C was excluded, the structure of the 3rd network differed from the original in four arcs after bootstrapping (Fig 1). The final network had 15 nodes, 16 arcs, and an average Markov blanket size of 2.93.

Fig 1. Dynamic Bayesian network excluding the coagulation node.

Fig 1

The Dynamic Bayesian network without the coagulation node (C) at three time points (t0 = the day of ICU admission; t2 = 2nd day and t7 = 7th day) after bootstrapping.

Among the four tested networks, the fourth one, which included 5 variables measured at t0, t2 and t7, had a strength of more than 0.67 for all arcs, and the minimum number of time points still retained relevant clinical information. In Table 1, we included parameters (namely, the strength and direction) to estimate the accuracy of the DBN regarding five organs evaluated at t0 and on the 2nd and 7th days.

Table 1. Arcs strength and direction of the averaged dynamic Bayesian network obtained by 500 bootstrap on five organs at the intensive care unit admission, at 2nd and 7th day.
From To strength direction
Kidneyt0 Kidneyt2 1.00 0.79
Kidneyt0 Lungt2 1.00 1.00
Livert0 Livert2 0.98 0.62
Lungt0 Lungt2 1.00 1.00
Lungt0 Cardiovasculart2 1.00 1.00
Cardiovasculart0 Cardiovasculart2 1.00 1.00
Central Nervous Systemt0 Central Nervous Systemt2 1.00 1.00
Kidneyt2 Kidneyt7 1.00 0.94
Livert2 Livert7 1.00 0.80
Livert2 Cardiovasculart7 1.00 1.00
Lungt2 Lungt7 1.00 1.00
Cardiovasculart2 Central Nervous Systemtt2 0.67 0.91
Cardiovasculart2 Cardiovasculart7 1.00 0.99
Central Nervous Systemt2 Central Nervous Systemt7 1.00 0.98
Cardiovasculart7 Lungt7 0.94 0.79
Cardiovasculart7 Central Nervous Systemt7 0.96 0.85

The day of the intensive care unit admission: t0; the 2ndday of intensive care unit stay: t2; the 7th day of intensive care unit stay: t7.

The reliability of this network prediction was supported by the cross-validation results which indicated high sensitivity and specificity for almost all nodes (Table 2).

Table 2. The sensitivity and specificity of the final network prediction tested with the k-fold cross-validation analysis.
Variable sensitivity specificity
Central Nervous System t2 0.90 0.88
Kidney t2 0.76 0.98
Lung t2 0.70 0.69
Cardiovascular t2 0.79 0.83
Liver t2 0.32 0.96
Central Nervous System t7 0.80 0.89
Kidney t7 0.72 0.98
Lung t7 0.21 0.97
Cardiovascular t7 0.21 0.99
Liver t7 0.70 0.99

The 2ndday of intensive care unit stay: t2; the 7th day of intensive care unit stay: t7.

Conditional probabilities

We fitted the conditional probability distributions for the arcs of the last network with five variables (excluding platelets), and three time periods (admission, 2nd day and 7th day). The resulting probability matrices are reported in S1S3 Figs.

Kidney and liver failure at the time of admission had a 72% and 51% probability, respectively, of persisting to the 2nd day. The probabilities of these organ failures persisting from the 2nd day to the 7th day were higher, at 86% and 69%, respectively. CV failure had a 70% probability of persisting to the 2nd day when associated with lung failure on ICU admission, whereas the probability decreased to 66% in the absence of this association. Similarly, lung failure on admission had a 69% probability of persisting to the 2nd day when associated with kidney failure, whereas this probability was only 49% in the absence of this association. CNS failure on admission had a 71% probability of persisting to the 2nd day, but when associated with CV on the 2nd day, its probability increased to 75%. The probability of CNS failure persisting from the 2nd to the 7thday was 60%, but it increased to 86% when CV failure was present on the 7th day. The probability that CV failure on the 2ndday would persist to the 7thday was 72% in association with liver failure but 62% in the absence of this association. Finally, lung failure on the 2ndday showed a 58%probability of persisting to the 7th day, but the probability increased to 67% when CV failure was also present. In Fig 2, we report the types of organ failure and their associations with increased probabilities of progression during the observation time of our study.

Fig 2. Percentage probabilities of the organ failure progression.

Fig 2

The day of the intensive care unit admission: t0; the 2nd day after the intensive care unit admission: t2; the 7th day after the intensive care unit admission: t7. Percentage numbers: conditioned probability to progress at 2nd and 7 dayth.

Network reliability

Our results demonstrated the feasibility of achieving a sufficiently reliable DBN model to predict the association of organ failures and their evolution regardless of a predetermined final outcome. Our previous study focused on predicting sequences of organ failure but used a node “discharge” in the DBN [6]. The current study overcomes the limitation of using a predefined outcome and allows the network structure to learn from data. In addition, we used a learning algorithm strategy to estimate the conditional probabilities.

Defining an optimal network structure that learns its parameters is a complex computational problem. The number of structures to be tested can be large, and providing a good estimate of probabilities requires a large volume of data to be processed. In order to define the network structure that best describes data and relationships among variables, two different approaches can be used: a “global” approach [21], which employs search and score algorithms for data description, and a “local” approach [22, 23], which utilizes conditional independent tests to evaluate relationships. This latter approach derives the best structure representing relationships. The search and score methods proceed by creating several network structures suitable to describe data and assign scores to them with a specific scoring function. After comparing scores, a search algorithm identifies the most representative network structure. These steps are needed to limit the number of networks to be evaluated, reducing the computational load.

In our study, we applied the HC heuristic research method, a “local” approach that is applied when the graph is unknown [18], to improve data fitting despite the large number of organs (6) and the long examination period (7 days). To obtain the best network fit and increase its accuracy, we reduced the number of timepoints instead of organs, leaving information on organ failure events unchanged.

To reduce the network complexity due to the number of organ, we removed only the “coagulation” metric, as platelet counts during sepsis should ordinary be increased by supportive actions focused on fully treating the spread of infection than by a specific intervention [24].

Network accuracy

We found several organ failure associations with an increased probability of occurring and progressing over time. Our model reported only conditional probabilities resulting from arcs between organs. A network with three time points and five organs proved to be sufficiently accurate for our intended clinical purposes. At the time of ICU admission, a real connection between organs was unlikely to occur, and there is a low probability of evidence connecting the failure of these organs. In contrast, the persistence of organ failure during the ICU stay was more probable when multiple failing organs were associated.

Information derived from our network model provides incentives for clinical reasoning. Any clinical reasoning should be based on an understanding of the relationships among the elements that are relevant to the individual clinical case; thus, the characteristics of the elements forming the basis of the reasoning assessment become crucial. When BNs associate probabilities with a single outcome (life or death) or composite outcomes, they furnish information similar to what is derived from severity scores, but the Bayesian perspective can supply other elements, in terms of organ failure, that allow enrichment of clinical reasoning. In fact, it is likely that the associations and sequences of organ failure in a given population result from treatments and clinical approaches adopted by clinicians. Avoiding predefined outcomes leads to other perspectives, such as adopting therapeutic strategies to change the scenario of organ damage.

Our study has several limitations. We restricted our node to the presence of organ failure, neglecting its severity. The need to attribute a weight to the organ associations rather than to the severity of failure has limited the Bayesian model we adopted. Adopting a graded intensity scale for organ damage could increase the available clinical information in the near future while not interfering with the ability to detect probabilities of organ relationships. Another factor that could interfere with the real evaluation of organ failure is external support given to organ function. This issue is also present for all the predictive scores [25] and leads to the consideration of external organ support as an integral part of organ function evaluation. Finally, given the size of our dataset, we built a robust network structure using only three time slices and five organs. More specifics regarding the time course of organ failure may be useful with a larger number of patients.

Conclusions

In this study, we applied an innovative approach for testing the reliability and accuracy of a DBN model aimed to avoid imposing predefined outcomes. We realized a network model that allowed us to predict with satisfactory accuracy several organ failure associations and their evolution in critically ill patients. As the organ failure sequences likely resulted from the clinical choices adopted, our method has the potential advantage of detecting the effects of treatments or therapeutic strategies on organ function and comparing these effects on populations treated differently. Further analysis is needed to test the accuracy of a network model able to assess the severity of organ dysfunction and determine whether it could add useful knowledge in clinical settings.

Supporting information

S1 Fig. Percentage conditioned probability of failing organs and organs associations at the intensive care unit admittance.

Horizontal axis: percentage probability. Vertical axis: present 1. Absent 0. Intensive care unit admittance: t0. Organ on the rectangles border: associated organ.

(TIF)

S2 Fig. Percentage conditioned probability of failing organs and organs associations at the 2nd day of the intensive care stay.

Horizontal axis: percentage probability. Vertical axis: present 1. Absent 0. Intensive care unit admittance: t0. Organ on the rectangles border: associated organ.

(TIF)

S3 Fig. Percentage conditioned probability of failing organs and organs associations at the 7th day of the intensive care stay.

Horizontal axis: percentage probability. Vertical axis: present 1. Absent 0. Intensive care unit admittance: t0. Organ on the rectangles border: associated organ.

(TIF)

Acknowledgments

We acknowledge dr. Mario Tavola (chief of the Intensive Care Unit of the A. Manzoni Hospital of Lecco—Italy) and dr. Romano Tetamo (chief of the Anesthesia and Intensive Care Medicine of the Di Cristina-Benfratelli Civic Hospital of Palermo—Italy) for having made available data from patients admitted in their Units.

Data Availability

The datasets generated and/or analyzed during the current study are anonymously available on the following repository: DANS.https://doi.org/10.17026/dans-zgz-7keg. DATASET SOFA.

Funding Statement

Giuseppe Campagna received a fund for data analysis from the research funds of the Dipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale of University of Rome “La Sapienza” for the analysis of data (n. 000323_19 master del.04.03.020; PI: GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Bueno MLP, Hommersom A, Lucas PJF, Lappenschaar M, Janzing JGE. Understanding disease processes by partitioned dynamic Bayesian networks. J Biomed Inform. 2016;61: 283–297. 10.1016/j.jbi.2016.05.003 [DOI] [PubMed] [Google Scholar]
  • 2.Daly R, Shen Q, Aitken S. Learning Bayesian networks: approaches and issues. Knowl Eng Rev. 2011;26: 99–157. [Google Scholar]
  • 3.VanderWeele TJ. Outcome-wide epidemiology. Epidemiology. 2017;28: 399–402. 10.1097/EDE.0000000000000641 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Armstrong PW, Westerhout CM. Composite end points in clinical research. Circulation. 2017;135: 2299–2307. 10.1161/CIRCULATIONAHA.117.026229 [DOI] [PubMed] [Google Scholar]
  • 5.Ghahramani Z. Learning Dynamic Bayesian Networks. Adaptive Processing of Sequences and Data Structures. International Summer School on Neural Networks, ‘‘ER Caianiello”-Tutorial Lectures: Springer-Verlag; 1998. pp. 168–197. [Google Scholar]
  • 6.Sandri M, Berchialla P, Baldi I, Gregori D, De Blasi RA. Dynamic Bayesian Networks to predict sequences of organ failures in patients admitted to ICU. J Biomed Inform. 2014;48: 106–113. 10.1016/j.jbi.2013.12.008 [DOI] [PubMed] [Google Scholar]
  • 7.Lucas PJ, Van der Gaag LC, Abu-Hanna A. Bayesian Networks in biomedicine and health-care. Artif Intell Med. 2004;30: 201–214. 10.1016/j.artmed.2003.11.001 [DOI] [PubMed] [Google Scholar]
  • 8.Oda S, Hirasawa H, Sugai T, Shiga H, Nakanishi K, Kitamura N, et al. Comparison of Sepsis-related Organ Failure Assessment (SOFA) score and CIS (cellular injury score) for scoring of severity for patients with multiple organ dysfunction syndrome (MODS). Int Care Med. 2000;26: 1786–1793. [DOI] [PubMed] [Google Scholar]
  • 9.Jeschke MG. Unusual relationship: Do organs talk to each other? Critical Care. 2016;44: 1950–1951. 10.1097/CCM.0000000000001930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Peelen L, de Keizer NF, de Jonge E, Bosman RJ, Abu-Hanna Ameen, Peek N. Using hierarchical dynamic Bayesian networks to investigate dynamics of organ failure in patients in the intensive care unit. J Biomed Inform. 2010; 43:273–286 10.1016/j.jbi.2009.10.002 [DOI] [PubMed] [Google Scholar]
  • 11.Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Working group on “sepsis-related problems” of the European society of intensive care medicine. Crit Care Med. 1998;26: 1793–8000. 10.1097/00003246-199811000-00016 [DOI] [PubMed] [Google Scholar]
  • 12.Vincent JL, Moreno R, Takala J, de Mendoca A, Bruining H, Reinhart CK, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22: 707–710. 10.1007/BF01709751 [DOI] [PubMed] [Google Scholar]
  • 13.Short RD, Fukunaga K. The optimal distance measure for nearest neighbor classification. IEEE Trans Inf Theory. 1981;27: 622–627 [Google Scholar]
  • 14.van der Heijden M, Velikova M, Lucas PJ. Learning Bayesian networks for clinical time series analysis. J Biomed Inform. 2014;48: 94–105 10.1016/j.jbi.2013.12.007 [DOI] [PubMed] [Google Scholar]
  • 15.Dempster A, Laird N, Rubin D. Maximum likelihood from incomplete data via the em algorithm. J R Stat Soc, Ser B. 1977;39:1–38. [Google Scholar]
  • 16.Kjaerulff U. dHugin: a computational system for dynamic time-sliced Bayesian networks. Int J Forecast. 1995;11: 89–111. [Google Scholar]
  • 17.Korb KB, Nicholson AE. Bayesian Artificial Intelligence. 2nd ed. CRC Press; 2011 [DOI] [PubMed] [Google Scholar]
  • 18.Sucar LE. Probabilistic graphical models. Principles and applications. New York: Springer-Verlag; 2015. [Google Scholar]
  • 19.Nagarajan R, Scutari M, Lèbre S. Bayesian Networks in R with Applications in Systems Biology. New York: Springer-Verlag; 2013. [Google Scholar]
  • 20.Imoto S, Kim SY, Shimodaira H, Aburatani S, Tashiro K, Kuhara S, et al. Bootstrap Analysis of Gene Networks Based on Bayesian Networks and Nonparametric Regression. Genome Inform. 2002;13: 369–370. [Google Scholar]
  • 21.Cooper G, Herskovits E. A Bayesian method for the induction of probabilistic networks from data. Machine Learning. 1992;9: 309–347. [Google Scholar]
  • 22.Chickering D, Heckerman D, Meek C. A Bayesian approach to learning Bayesian networks with local structure. In: Morgan K, editor. Proceedings of 13th Conference on Uncertainty in Artificial Intelligence. Providence, RI; 1997.
  • 23.Mania S, Cooper GF. Causal discovery using a Bayesian local causal discovery algorithm. In Fieschi M. et al. editors. MEDINFO IOS Press. Amsterdam; 2004. [PubMed] [Google Scholar]
  • 24.Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients? Br J Haematol. 2017;177: 27–38. 10.1111/bjh.14482 [DOI] [PubMed] [Google Scholar]
  • 25.Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315: 762–774. 10.1001/jama.2016.0288 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Moshe Zukerman

23 Dec 2020

PONE-D-20-33480

A dynamic Bayesian network model for predicting organ failure associations without predefining outcomes

PLOS ONE

Dear Dr. De Blasi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 06 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Moshe Zukerman

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was informed. If the need for additional consent was waived by the ethics committee, please include this information.

3. In the ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records/samples used in your retrospective study, including: a) whether all data were fully anonymized before you accessed them; b) the date range (month and year) during which patients' medical records/samples were accessed.

4. In your Methods section, please provide additional information about the medical data/samples collected and the demographic details of the human subjects. Please ensure you have provided sufficient details to replicated the analyses such as a table of relevant demographic details.

5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

6. Please upload a new copy of Figure 1 as the detail is not clear. Please follow the link for more information: https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper represents a very interesting study with informative results. The overall structure of the paper is acceptable; however, it can be improved based on deploying the below ideas.

1. Using model stacking to improve accuracy as the model stacking maintain the interpretability of the DBN.

2. How the DBN network is initialized? I could not find any description or sentence that explains the network initialization before training?

3. Please use more creative approaches to illustrate your results. Since the paper claims at beginning, that the interpretability is one of their goals, but no data visualization approach is used for presenting the results.

4. Please provide a link to your code of the model in a public repository.

Reviewer #2: General comments:

Interesting and impactful application of DBN for a key problem as demonstrated by the discussions in the section beginning line 203. However, there are several key areas that are lacking in clarity, and major revision at minimum is needed to ensure that the research is significant, original and well justified.

The paper could benefit significantly from detailed review and proof-reading as sentence construction and grammar is at times quite poor. There are many instances (some examples are provided below) where:

(i) clarification is needed, and/or

(ii) citations / references are needed to justify a statement, and/or

(iii) justification of a design decision is needed.

There is insufficient detail about the implementation of the DBN and Figure 1 is illegible to enable scientific reproducibility or indeed assessment of the proposed work.

This model seems to be about *short term* multiple organ failure that occurs over the course of a days (6 days) – this needs to be clarified.

A key question for the developed models, however, is model validation. Validation appears to be missing even though line 191 alludes to network C “satisfy(ing) the accuracy requirements”. Without providing validation results, the reported findings are not necessarily reliable.

47: what do you mean by “…systems in which the relationship between variables is not completely known”? Are you studying and evaluating different graph structures like that done in BN learning (Daly, Shen, & Aitken, 2011)?

53: what do you mean here? Are you talking about using a model to determine if a therapeutic action contributed to a given outcome? Please clarify.

61: how did you select variables to include? What are the “values” to be included, are you referring to node states?

63: Clarify – was the graph entirely built using expert elicitation?

The description of the procedure you followed to build the network needs some justification and/or citations. Some examples of typical BN construction methodologies are discussed by (Johnson et al., 2010; Korb and Nicholson, 2010; Pollino, Woodberry, Nicholson, Korb, & Hart, 2007).

72: also needs references for these statements

The paper needs some review of existing studies and/or models of single and/or multi-organ failures – how are these failures currently modelled? What is the gap? Hence, what is the significance and contribution of the proposed approach?

90: why did you exclude young patients <18 years old and short hospital stays? What is the consequence of focusing on 2 or more organ failures?

96: what is i indexing, the patient?

100: “…considered to be failing if it had a score of >=2” – needs a citation

105: kNN for data imputation – however, the Expectation Maximisation (EM) algorithm typically used in BN learning is able to impute missing data using the entire BN and other data points. Why is it necessary to use kNN?

119: Markov assumption, not Markov blanket

125: Not clear how you used bootstrapping – please describe briefly the procedure you used to learn the DBN and how you used the data.

Figure 1 is illegible

129: it is unclear how you have gone about building these different networks, how you used hill climbing, and how your approach is justified. This section needs much better clarity.

137: It is well known that a blacklist to prevent illogical arcs and a whitelist to force arcs is commonly needed and is supported by bnlearn and the papers around it – these should be cited. Also, for reproducibility, the specific blacklist and whitelists should be provided and justified.

REFERENCES

Daly, R., Shen, Q., & Aitken, S. (2011). Learning Bayesian networks: approaches and issues. The Knowledge Engineering Review, 26(02), pp. 99-157. doi:doi:10.1017/S0269888910000251 Retrieved from http://dx.doi.org/10.1017/S0269888910000251

Johnson, S., Mengersen, K., Waal, A. d., Marnewick, K., Cilliers, D., Houser, A. M., & Boast, L. (2010). Modelling cheetah relocation success in southern Africa using an Iterative Bayesian Network Development Cycle. Ecological Modelling, 221, pp. 641-651.

Korb, K. B., & Nicholson, A. E. (2010). Bayesian Artificial Intelligence, Second Edition: CRC Press, Inc.

Pollino, C. A., Woodberry, O., Nicholson, A., Korb, K., & Hart, B. T. (2007). Parameterisation and evaluation of a Bayesian network for use in an ecological risk assessment. Environmental Modelling and Software, 22(8), pp. 1140-1152.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Omid Bazgir

Reviewer #2: Yes: Paul Pao-Yen Wu

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Apr 28;16(4):e0250787. doi: 10.1371/journal.pone.0250787.r002

Author response to Decision Letter 0


22 Feb 2021

Reviewer #1: This paper represents a very interesting study with informative results. The overall structure of the paper is acceptable; however, it can be improved based on deploying the below ideas.

1. Using model stacking to improve accuracy as the model stacking maintain the interpretability of the DBN.

We agree with the reviewer that model stacking should improve the accuracy of model prediction by efficiently aggregating the results of several models. Nevertheless, as our primary aim was proving that the BN structure for failing organs probabilistic interaction and evolution was robust and led to a clinically sensible interpretation, we believe that a simpler boostrap validation of the model structure can be appropriate. In this manuscript revision, we have extended Materials and methods and better explained how we have generated the network structure and the boostrap validation in - Dynamic Bayesian Network formulation (page 5, lines 135-145).

2. How the DBN network is initialized? I could not find any description or sentence that explains the network initialization before training?

The network structure was learned from data using the hill-climbing algorithm provided by the R package bnlearn, starting from an empty network (a network with no arcs). The score used in the optimization process was the Bayesian information criterion. We have provided these details about network construction in the section Materials and methods - Dynamic Bayesian Network formulation (lines 128-135). We have also added in methods how we estimated the network probability matrices on the arcs. This is equivalent to using a maximum a posteriori estimation from a uniform prior distribution of the parameters.

3. Please use more creative approaches to illustrate your results. Since the paper claims at beginning, that the interpretability is one of their goals, but no data visualization approach is used for presenting the results.

We apologize for the scarcity of our results visualization. In this revised version we have modified the Bayesian network in figure 1 to make it clearer (line 182) and added another figure of the most significant conditioned probabilities for the organ failure onset, their associations and progressions (figure 2) (line 226). For further information, we have also added, as supporting figures, extended documentation of the percentage probabilities for the organ failure and their associations at the three time points (line 210).

4. Please provide a link to your code of the model in a public repository.

We have sent our dataset to the public repository DANS-EASY Electronic Archiving System DANS.https://doi.org/10.17026/dans-zgz-7keg (Page 7, lines 163).

Reviewer #2: General comments:

Interesting and impactful application of DBN for a key problem as demonstrated by the discussions in the section beginning line 203. However, there are several key areas that are lacking in clarity, and major revision at minimum is needed to ensure that the research is significant, original and well justified.

The paper could benefit significantly from detailed review and proof-reading as sentence construction and grammar is at times quite poor. There are many instances (some examples are provided below) where:

(i) clarification is needed, and/or

(ii) citations / references are needed to justify a statement, and/or

(iii) justification of a design decision is needed.

There is insufficient detail about the implementation of the DBN and Figure 1 is illegible to enable scientific reproducibility or indeed assessment of the proposed work.

We have improved the description of procedures adopted to implement the DBN in methods with references to the R-package we used (Page 5, lines 128).

This model seems to be about *short term* multiple organ failure that occurs over the course of a days (6 days) – this needs to be clarified.

We have accepted the reviewer’s suggestions: “short term” has been added in the introduction (line 80) and the reason why our study extended over a period of 7 days has been reported in Methods (line 105).

A key question for the developed models, however, is model validation. Validation appears to be missing even though line 191 alludes to network C “satisfy(ing) the accuracy requirements”. Without providing validation results, the reported findings are not necessarily reliable.

We are aware that model validation has a key role for findings reliability. In this revision, we have applied a k-fold cross-validation analysis to the final network. We computed sensitivities and specificities of the predictions of child nodes from parent nodes. We have added several details in Methods for the cross-validation analysis and a table (table 2) (line 201) showing predictive sensitivity and specificity.

47: what do you mean by “…systems in which the relationship between variables is not completely known”? Are you studying and evaluating different graph structures like that done in BN learning (Daly, Shen, & Aitken, 2011)?

We have rephrased the first sentence of introduction clarifying the BNs characteristics we considered for our study including the suggested reference [2].

53: what do you mean here? Are you talking about using a model to determine if a therapeutic action contributed to a given outcome? Please clarify.

We agree with the reviewer that sentences (line 53-61) needed to be clarified. We have now specified that we considered probabilities of failing organs as reflecting the effects of treatments (lines 52-56). In the Conclusions we have resumed this concept and extended its possible clinical applications (lines 294-296).

61: how did you select variables to include? What are the “values” to be included, are you referring to node states?

63: Clarify – was the graph entirely built using expert elicitation?

The paper needs some review of existing studies and/or models of single and/or multi-organ failures – how are these failures currently modelled? What is the gap? Hence, what is the significance and contribution of the proposed approach?

Based on the reviewer observations, we have realized that paragraph from line 61 was confusing and poorly comprehensible. In this version we have completely revised it, anticipating the aim of our work and highlighting differences with existing studies and contribution of our approach (line 60-83). We have also added references, reduced sentences, corrected unclear terms and attempted to make the text clearer.

The description of the procedure you followed to build the network needs some justification and/or citations. Some examples of typical BN construction methodologies are discussed by (Johnson et al., 2010; Korb and Nicholson, 2010; Pollino, Woodberry, Nicholson, Korb, & Hart, 2007).

72: also needs references for these statements

We have provided more details about the procedures we followed to learn the network structure and fit its conditional probabilities including references in Materials and methods - Dynamic Bayesian Network formulation. We added as supporting information the resulting probability matrices (S1-S3).

90: why did you exclude young patients <18 years old and short hospital stays? What is the consequence of focusing on 2 or more organ failures?

We regret for not having reported that the study was realized in adult ICUs and no patients under 18 years old had criteria to be included in the study. In this revision we have clarified this (line 89) and deleted “under 18 years old” from the exclusion criteria. We have also explained why we focused on 2 or more organ failures (line 92).

100: “…considered to be failing if it had a score of >=2” – needs a citation

We have included a reference to the sentence (line 104).

105: kNN for data imputation – however, the Expectation Maximisation (EM) algorithm typically used in BN learning is able to impute missing data using the entire BN and other data points. Why is it necessary to use kNN?

We agree with the reviewer in considering the kNN not necessary. Therefore, we have deleted the kNN from the manuscript.

119: Markov assumption, not Markov blanket

We have changed “blanket” in “assumption” as suggested (line 123).

125: Not clear how you used bootstrapping – please describe briefly the procedure you used to learn the DBN and how you used the data.

In this manuscript revision, we have clarified how we used bootstrapping by adding the description of procedures we adopted to learn the DBNs (page 5, line 128) and a reference [19] (Nagarajan R, Scutari M, Lèbre S. Bayesian Networks in R. New York: Springer-Verlag; 2013).

Figure 1 is illegible:

We have changed figure 1 attempting to make it clearer for readers.

129: it is unclear how you have gone about building these different networks, how you used hill climbing, and how your approach is justified. This section needs much better clarity.

We have added a detailed description on the approach we used for the network construction and hill climbing in Methods (page 5, line 129-138).

137: It is well known that a blacklist to prevent illogical arcs and a whitelist to force arcs is commonly needed and is supported by bnlearn and the papers around it – these should be cited. Also, for reproducibility, the specific blacklist and whitelists should be provided and justified.

In this revision, we have disclosed in the introduction (line 80) the use of the blacklist we adopted in learning the DBN structure according to the aims of our work and provided a description of the blacklist characteristics in Methods-Dynamic Bayesian Network formulation (line 131).

Decision Letter 1

Moshe Zukerman

16 Mar 2021

PONE-D-20-33480R1

A dynamic Bayesian network model for predicting organ failure associations without predefining outcomes

PLOS ONE

Dear Dr. De Blasi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 30 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Moshe Zukerman

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors took care of the my previous comments pretty well and all my concerns in the previous round of review were addressed in the current revision.

Reviewer #2: The authors have done an admirable job addressing the comments and the paper is offers more comprehensive detail and clarity on the approach. I appreciate the inclusion of the conditional probability tables in the supporting information too, that is important for reproducibility of the research. I still think that the paper would benefit from some final, professional, proof-reading. I have attached below some minor clarifications:

Line 69: I understand that imposing constraints may limit the ability of the model to reflect the data; however, the data itself may not truly represent the complex system that is MODS.

I would suggest: “On the other hand, imposing an ordering and constraints on the probabilistic relationships between organs and processes can limit the ability of the model to reflect the data.”

Line 75: “…dynamics of failing organs by hierarcizing organ interactions and forcing a discrete outcome… ”

Line 81: “…structure of a short-term DBN from data with Markovian constraints enforced through a blacklist.”

Line 103: did you mean “A failure event for an organ was defined as a SOFA score of greater than or equal to two”.

Line 133: “and enforce Markovian properties…”

Line 136 paragraph – very good clarification!

Line 151 – what is node C, is it the platelet number (if so, say that here)

Line 187 – need to check grammar here!

Line 260 – loops violating the Directed Acyclic Graph (DAG) assumption of BNs. Markov assumption is something else.

Sometimes there is shorthand (e.g. L instead of Lung) – please be consistent

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Omid Bazgir

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Apr 28;16(4):e0250787. doi: 10.1371/journal.pone.0250787.r004

Author response to Decision Letter 1


1 Apr 2021

To: Moshe Zukerman

Academic Editor

PLOS ONE

Dear Editor,

we have revised the manuscript responding to each point raised by the reviewer #2. The manuscript has undergone a further English editing by the SpringerNature Author Service company on March 23, 2021 (verification code certification: 906E-C0AA-00AD-B5B9-4803). In the 'Revised Manuscript with Track Changes' we have corrected some grammar errors and highlighted the changes of the English form (yellow) and the changes suggested by the reviewer (green). We have not modified references or figures.

Best regards.

Roberto A. De Blasi

Review Comments to the Author

Reviewer #2: The authors have done an admirable job addressing the comments and the paper is offers more comprehensive detail and clarity on the approach. I appreciate the inclusion of the conditional probability tables in the supporting information too, that is important for reproducibility of the research. I still think that the paper would benefit from some final, professional, proof-reading. I have attached below some minor clarifications:

Line 69: I understand that imposing constraints may limit the ability of the model to reflect the data; however, the data itself may not truly represent the complex system that is MODS.

I would suggest: “On the other hand, imposing an ordering and constraints on the probabilistic relationships between organs and processes can limit the ability of the model to reflect the data.”

We have revised line 69 as suggested by the reviewer (line 70).

Line 75: “…dynamics of failing organs by hierarcizing organ interactions and forcing a discrete outcome.. ”

We have accepted the reviewer’s suggestion.

Line 81: “…structure of a short-term DBN from data with Markovian constraints enforced through a blacklist.”

We have revised line 79 taking into account the reviewer’s suggestion.

Line 103: did you mean “A failure event for an organ was defined as a SOFA score of greater than or equal to two”.

We have revised line 103 as suggested by the reviewer because it’s more comprehensible

Line 133: “and enforce Markovian properties…”

We have corrected the sentence at line 133 as suggested (line 131).

Line 151 – what is node C, is it the platelet number (if so, say that here)

We have clarifies that node C refers to the platelet count (line 149).

Line 187 – need to check grammar here!

We have completely revised the sentence (line 185-187).

Line 260 – loops violating the Directed Acyclic Graph (DAG) assumption of BNs. Markov assumption is something else.

As the sentence was not conceptually correct and did not add substantial knowledge at the discussion, we have deleted the whole sentence at lines 259-261.

Sometimes there is shorthand (e.g. L instead of Lung) – please be consistent

As the “L” abbreviation could be confounding, we have deleted this shorthand and inserted the full name “liver”

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Moshe Zukerman

14 Apr 2021

A dynamic Bayesian network model for predicting organ failure associations without predefining outcomes

PONE-D-20-33480R2

Dear Dr. De Blasi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Moshe Zukerman

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The comments have been adequately addressed from the two rounds of review and revisions, thank you!

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Paul Pao-Yen Wu

Acceptance letter

Moshe Zukerman

16 Apr 2021

PONE-D-20-33480R2

A dynamic Bayesian network model for predicting organ failure associations without predefining outcomes

Dear Dr. De Blasi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Moshe Zukerman

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Percentage conditioned probability of failing organs and organs associations at the intensive care unit admittance.

    Horizontal axis: percentage probability. Vertical axis: present 1. Absent 0. Intensive care unit admittance: t0. Organ on the rectangles border: associated organ.

    (TIF)

    S2 Fig. Percentage conditioned probability of failing organs and organs associations at the 2nd day of the intensive care stay.

    Horizontal axis: percentage probability. Vertical axis: present 1. Absent 0. Intensive care unit admittance: t0. Organ on the rectangles border: associated organ.

    (TIF)

    S3 Fig. Percentage conditioned probability of failing organs and organs associations at the 7th day of the intensive care stay.

    Horizontal axis: percentage probability. Vertical axis: present 1. Absent 0. Intensive care unit admittance: t0. Organ on the rectangles border: associated organ.

    (TIF)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The datasets generated and/or analyzed during the current study are anonymously available on the following repository: DANS.https://doi.org/10.17026/dans-zgz-7keg. DATASET SOFA.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES